Brain tissue from Alzheimer's disease patients exhibits synaptic degeneration in selected regions. Synaptic dysfunction occurs early in the disease and is a primary pathological target for treatment. The molecular mechanisms underlying this degeneration remain unknown. Quantifying the synaptic proteome in autopsy brain and comparing tissue from Alzheimer's disease cases and subjects with normal aging are critical to understanding the molecular mechanisms associated with Alzheimer pathology. We isolated synaptosomes from hippocampus and motor cortex so as to reduce sample complexity relative to whole-tissue homogenates. Synaptosomal extracts were subjected to strong cation exchange (SCX) fractionation to further partition sample complexity; ...
Cognitive changes occurring throughout the pathogenesis of neurodegenerative diseases are directly l...
Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common cause of dementia world...
Neurodegenerative disorders progress across the brain in characteristic spatio-temporal patterns. A ...
Background: Synaptic dysfunction occurs early in Alzheimer's disease (AD) and is recognized to be a ...
Brain tissue from Alzheimer's disease (AD) patients shows significant loss of synapses in selected r...
Purpose: Synaptic dysfunction occurs early in Alzheimer’s disease (AD) and is recognized as a primar...
The purpose of this study was to identify changes in protein expression that occur in the hippocampu...
The mammalian nervous system is an immensely heterogeneous organ composed of a diverse collection of...
Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by intracellular forma...
Abstract Alzheimer’s disease (AD) is a complex neurodegenerative disorder with impaired protein acti...
Neurodegenerative disorders, including Alzheimers disease (AD), are prevalent among the elderly. Sma...
Abstract Proteomic studies of human Alzheimer’s disease brain tissue have potential to identify prot...
Alzheimer’s disease (AD) is the most prevalent form of dementia affecting the elderly, and as the ag...
Alzheimer\u27s disease (AD) is the most common cause of dementia in western countries. The main neur...
Chapter 2 first establishes that the probability of detection in proteomics depends on the concentra...
Cognitive changes occurring throughout the pathogenesis of neurodegenerative diseases are directly l...
Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common cause of dementia world...
Neurodegenerative disorders progress across the brain in characteristic spatio-temporal patterns. A ...
Background: Synaptic dysfunction occurs early in Alzheimer's disease (AD) and is recognized to be a ...
Brain tissue from Alzheimer's disease (AD) patients shows significant loss of synapses in selected r...
Purpose: Synaptic dysfunction occurs early in Alzheimer’s disease (AD) and is recognized as a primar...
The purpose of this study was to identify changes in protein expression that occur in the hippocampu...
The mammalian nervous system is an immensely heterogeneous organ composed of a diverse collection of...
Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by intracellular forma...
Abstract Alzheimer’s disease (AD) is a complex neurodegenerative disorder with impaired protein acti...
Neurodegenerative disorders, including Alzheimers disease (AD), are prevalent among the elderly. Sma...
Abstract Proteomic studies of human Alzheimer’s disease brain tissue have potential to identify prot...
Alzheimer’s disease (AD) is the most prevalent form of dementia affecting the elderly, and as the ag...
Alzheimer\u27s disease (AD) is the most common cause of dementia in western countries. The main neur...
Chapter 2 first establishes that the probability of detection in proteomics depends on the concentra...
Cognitive changes occurring throughout the pathogenesis of neurodegenerative diseases are directly l...
Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common cause of dementia world...
Neurodegenerative disorders progress across the brain in characteristic spatio-temporal patterns. A ...